The effectiveness of nonprofits shouldn’t be based on how little they spend on overhead; that keeps their benchmarks too low. No one cares how much money it takes to develop a lifesaving drug. All they care about is that the drug works, that it offers a competitive return on investment, and that it gets into the hands of those who need it.
